Provectus Biopharmaceuticals, Inc. Stock
Stocks
PVCT
US74373P1084
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
OTC Markets
03:37:28 2026-06-02 pm EDT
|
5-day change | 1st Jan Change | ||
| 0.0620 USD | -7.32% |
|
+3.33% | +10.91% |
| Market Cap | 23.49M 20.36M 19.21M 17.43M 32.69M 2.25B 32.93M 229M 88.41M 1.14B 88.24M 86.29M 3.63B | P/E 2024 |
-10.6x | P/E 2025 | -4.33x |
|---|---|---|---|---|---|
| Enterprise Value | 26.22M 22.72M 21.44M 19.45M 36.49M 2.51B 36.75M 256M 98.68M 1.27B 98.48M 96.31M 4.05B | EV / Sales 2024 |
86,451,912x | EV / Sales 2025 | 78,013,766x |
| Free-Float |
92.52% | Yield 2024 * |
-
| Yield 2025 | - |
Last Transcript: Provectus Biopharmaceuticals, Inc.
| 1 day | -7.32% | ||
| 1 week | +3.33% | ||
| Current month | +9.66% | ||
| 1 month | +13.04% | ||
| 3 months | +2.31% | ||
| 6 months | +7.83% | ||
| Current year | +10.91% |
| 1 week | 0.05 | 0.07 | |
| 1 month | 0.05 | 0.07 | |
| Current year | 0.04 | 0.08 | |
| 1 year | 0.04 | 0.09 | |
| 3 years | 0.04 | 0.22 | |
| 5 years | 0.03 | 0.22 | |
| 10 years | 0.01 | 0.22 |
| Manager | Title | Age | Since |
|---|---|---|---|
Edward Pershing
CEO | Chief Executive Officer | 73 | 2024-04-15 |
Eric Wachter
CTO | Chief Tech/Sci/R&D Officer | 62 | 2012-05-14 |
Heather Raines
DFI | Director of Finance/CFO | 59 | 2019-03-24 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 57 | 2017-04-02 | |
John Lacey
BRD | Director/Board Member | 78 | 2018-04-26 |
Edward Pershing
CHM | Chairman | 73 | 2018-04-26 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 9/11/26 | Exercice | Chief Executive Officer | -13,216 | 0.1400% | ||
| 9/4/26 | Exercice | Chief Executive Officer | -11,328 | 0.1200% | ||
| 8/26/26 | Exercice | Chief Executive Officer | -11,328 | 0.1200% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -7.32% | +3.33% | -10.14% | -32.55% | 23.49M | ||
| +5.04% | +3.66% | +50.62% | +103.77% | 70.24B | ||
| -0.88% | -0.65% | +34.83% | +75.44% | 62.63B | ||
| -3.18% | -0.78% | -14.14% | +369.82% | 27.36B | ||
| +0.12% | -0.32% | +26.52% | +11.94% | 25.71B | ||
| +2.20% | -4.72% | +2.19% | -13.14% | 24.83B | ||
| -1.30% | -3.46% | +17.48% | -21.66% | 19.52B | ||
| -7.03% | -10.19% | +161.91% | +303.00% | 15.51B | ||
| -4.36% | -5.66% | -9.55% | +482.78% | 14.66B | ||
| +4.96% | +4.63% | -2.75% | +864.40% | 14.69B | ||
| Average | -1.17% | -1.64% | +25.70% | +214.38% | 27.52B | |
| Weighted average by Cap. | +0.53% | -0.80% | +31.83% | +167.78% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 0.62 0.53 0.5 0.46 0.86 59.15 0.87 6.03 2.32 30.01 2.32 2.27 95.4 | 0.34 0.29 0.27 0.25 0.47 32.21 0.47 3.28 1.26 16.34 1.26 1.23 51.96 |
| Net income | -4.76M -4.13M -3.89M -3.53M -6.63M -456M -6.68M -46.51M -17.92M -232M -17.89M -17.49M -736M | -5.43M -4.71M -4.44M -4.03M -7.56M -521M -7.61M -53.04M -20.44M -264M -20.4M -19.95M -839M |
| Net Debt | 2.88M 2.49M 2.35M 2.13M 4M 276M 4.03M 28.1M 10.83M 140M 10.81M 10.57M 445M | 2.73M 2.36M 2.23M 2.02M 3.8M 261M 3.82M 26.64M 10.26M 133M 10.24M 10.02M 422M |
Employees
6
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-14 | $0.0559 | -1.24% | 1,383 |
| 26-09-11 | $0.0566 | +5.60% | 41,500 |
| 26-09-10 | $0.0536 | +1.71% | 177,617 |
| 26-09-09 | $0.0527 | -0.75% | 52,072 |
- Stock Market
- Stocks
- PVCT Stock
Select your edition
All financial news and data tailored to specific country editions
















